|
Enkova E.V., Obernikhin K.I., Enkova V.V., Smetankina A.V.
Complex biologically active supplement with probiotic action in the treatment of vaginal biotope disorders in women during the perimenopausal transition (observational case-control study)
|
№3 / 2025
|
|
Bychkova A.E., Apolikhina I.A., Mkrtchyan L.S., Tarnaeva L.A.
Treatment of bacterial vaginosis in patients with cervical and uterine cancer in the late stages after antitumor treatment. Possibilities of using dequalinium chloride
|
№3 / 2025
|
|
Iurova M.V., Abakarova P.R., Mezhevitinova E.A., Aksenova A.V.
Vaginal microbiome and HPV persistence: the role of bacterial vaginosis in cervical carcinogenesis
|
№3 / 2025
|
|
Apolikhina I.A., Tarnaeva L.A.
Probiotics in the practice of a gynecologist: a new chapter in the treatment of vaginal infections and dysbiosis
|
№3 / 2025
|
|
Khryanin A.A., Knorring G.Yu.
Vaginal microbiome and the role of probiotics in maintaining women’s health
|
№5 / 2024
|
|
B.M. Aisaeva, G.B. Dikke, Z.A. Abusueva, P.Zh. Gitinova
Species diversity of the vaginal microbiota and local immune status in patients with recurrent bacterial vaginosis
|
№13 / 2023
|
|
I.G. Afanasyeva, I.O. Malova
Modern concepts of the vaginal microbiome and its significance in the pathogenesis of bacterial vaginosis
|
№8 / 2023
|
|
M.M. Rakhmatullayeva
Experience with two-stage therapy in the treatment of patients with bacterial vaginosis: long-term results of treatment
|
№4-5 / 2023
|
|
I.A. Kulikov, I.A. Apolikhina
Prospects for the use of metronidazole+miconazole in the treatment of mixed vaginal infections
|
№4-5 / 2023
|
|
N.Z. Mammaeva, I.B. Manukhin, K.A. Silaev
Modern features of the treatment of bacterial vaginosis in pregnant women
|
№6 / 2022
|
|
I.G. Afanasyeva, I.O. Malova
What is behind the mask of bacterial vaginosis?
|
№8 / 2021
|
|
M.M. Rakhmatullaeva
Treatment of bacterial vaginosis: problems and prospects
|
№6 / 2019
|
Русский
